JPRN-UMIN000005083已完成未知
the phase I study of chemotherapy with Docetaxel+Nedaplatin+5-FU(DNF) to esophageal cancer - the phase I study of DNF therapy to esophageal cancer
Gunma University Graduate School Department of General Surgical Science0 个研究点目标入组 18 人开始时间: 2011年2月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.It is the patient having an anaphylactic history for DOC, CDGP, 5-FU and polysorbate "80" component pharmaceutical. 2.Severe complicate disease (malignant hypertension, severe heart failure, liver failure, liver cirrhosis, diabetes mellitus under inadequate control, bleeding disorders) 3.Infectious disease with fever up 4.Regardless of presence of a cause, it is motor paralysis, the patient having peripheral neuropathy, severe edema 5.pleural effusion or cardiac effusion need to treatment. 6.The patient having active multiple primary cancer. 7.During the pregnancy or a pregnant female patient we are possible or are nursing. 8.The patient having the interstitial pneumonia that is apparent by chest X-rays or CT or pulmonary fibrosis 9.The patient whom we merge psychosis or neurologic manifestation, and it is judged to have difficulty with participation to an examination. 10.the case that resarch contact doctor regards as inadequate.
研究者
相似试验
已完成
2 期
the phase II study of chemotherapy with Docetaxel+Nedaplatin+5-FU(DNF) to esophageal cancerStageII,III,IV non-resective esophageal cancer and recurrece ofesophageal cancerJPRN-UMIN000005081Gunma University Graduate School Department of General Surgical Science30
已完成
1 期
PhaseI/II trial of chemotherapy with docetaxel, CDDP and 5-Fluorouracil followed by chemoradiotherapy with CDDP and 5-Fluorouracil in patients with locally advanced esophageal cancer.esophageal cancerJPRN-UMIN000003546Department of Surgical Oncology, Division of Clinical and Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University60
进行中（未招募）
1 期
First Line Dose-Dense Chemotherapy With Docetaxel, Cisplatin, Folinic Acid and 5- Fluorouracil plus Panitumumab in Patients With Locally Advanced or Metastatic Cancer of the Stomach or Gastro-Esophageal Junction: A Phase II Multicentre Trial - GOIRC 02/2009Patients with metastatic or locally advanced not resectable cancer of the stomach or gastro-esophageal junction.MedDRA version: 9.1Level: PTClassification code 10017758MedDRA version: 9.1Level: HLTClassification code 10030176EUCTR2009-016962-10-ITGRUPPO ONCOLOGICO ITALIANO DI RICERCA52
已完成
2 期
Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate CancerProstate CancerNCT00151047University of Michigan Rogel Cancer Center15
已完成
不适用
Adjuvant chemotherapy combined with docetaxel and cyclophosphamide for Japanese breast cancer patients without lymph node metastasis or with three and under lymph node metastasis.Breast cancerJPRN-UMIN000002310Gunma Breast Cancer Research Group 2 surgery90